Analytical Data
-
基因名
LPAR2
- Application
-
别名
LPAR2; EDG4; LPA2; Lysophosphatidic acid receptor 2; LPA receptor 2; LPA-2; Lysophosphatidic acid receptor Edg-4
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9HBW0
-
表达区间
1-348aa
-
氨基酸序列
MGQCYYNETIGFFYNNSGKELSSHWRPKDVVVVALGLTVSVLVLLTNLLVIAAIASNRRFHQPIYYLLGNLAAADLFAGVAYLFLMFHTGPRTARLSLEGWFLRQGLLDTSLTASVATLLAIAVERHRSVMAVQLHSRLPRGRVVMLIVGVWVAALGLGLLPAHSWHCLCALDRCSRMAPLLSRSYLAVWALSSLLVFLLMVAVYTRIFFYVRRRVQRMAEHVSCHPRYRETTLSLVKTVVIILGAFVVCWTPGQVVLLLDGLGCESCNVLAVEKYFLLLAEANSLVNAAVYSCRDAEMRRTFRRLLCCACLRQSTRESVHYTSSAQGGASTRIMLPENGHPLMDSTL
-
分子量
38.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human NDUFS2 Protein，His
Cat：PA1000-2121
Recombinant Human ATP5b Protein，His
Cat：PA2000-604DB
Protein Description
LPAR2 (Lysophosphatidic Acid Receptor 2) is a member of the G protein-coupled receptor family that plays a crucial role in various physiological processes, including cell proliferation, survival, migration, and differentiation. The research on LPAR2 has gained momentum due to its implications in several diseases, particularly cancer, fibrotic disorders, and neurological conditions. Lysophosphatidic acid (LPA), the endogenous ligand for LPAR2, is involved in several signaling pathways that can influence tumor microenvironments, contributing to cancer progression and metastasis. Given its significant role in these pathways, LPAR2 has emerged as a potential therapeutic target. Studies have shown that modulating LPAR2 activity can alter cellular responses in various contexts, making it an important subject of investigation for the development of novel treatments. Researchers are exploring LPAR2’s structure, function, and signaling mechanisms to better understand its role in disease and to identify small molecules or biologics that can selectively target this receptor. The elucidation of LPAR2 signaling pathways also offers insights into the broader field of signaling biology, making it an attractive target for drug discovery. Overall, the characterization and manipulation of LPAR2 through recombinant protein techniques and other biochemical approaches could pave the way for innovative therapeutic strategies in treating LPA-associated diseases.
